BI 765063
1443-0002
Phase 1 small_molecule active
Quick answer
BI 765063 for Head and Neck Squamous Cell Carcinoma (HNSCC) is a Phase 1 program (small_molecule) at Boehringer Ingelheim with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim
- Indication
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active